A2B530

News alerts, weekly reports and conference planners

Company:

A2 Biotherap

Drug class:

CEA-targeted CAR-T immunotherapy

Related drugs:

‹

›

HLA-A*02	Lung Cancer	HLA-A*02	Lung Cancer	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2
HLA-A*02	Pancreatic Cancer	HLA-A*02	Pancreatic Cancer	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2
HLA-A*02	Colorectal Cancer	HLA-A*02	Colorectal Cancer	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2	A2B530 Sensitive: C2 – Inclusion Criteria A2B530 Sensitive : C2

Associations
(3)